TABLE 1.
Parameter | Patient 1 (BCC)
|
Patient 2 (SCC)
|
||||
---|---|---|---|---|---|---|
Tumor
|
Normal
|
P Value | Tumor
|
Normal
|
P Value | |
Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |||
Optical absorption at 630 nm (cm−1) | 0.27 ± 0.03 | 0.21 ± 0.02 | <.0001 | 0.41 ± 0.06 | 0.32 ± 0.04 | <.0001 |
Optical scattering at 630 nm (cm−1) | 11.77 ± 1.20 | 14.97 ± 0.97 | <.0001 | 10.83 ± 2.47 | 13.77 ± 2.62 | <.0001 |
Optical penetration depth at 630 nm (mm) | 3.19 ± 0.51 | 3.25 ± 0.34 | <.0001 | 2.69 ± 0.73 | 2.74 ± 0.63 | <.0001 |
StO2 (%) | 82.30 ± 2.75 | 76.85 ± 6.23 | <.0001 | 83.74 ± 4.95 | 89.73 ± 2.60 | <.0001 |
THC (mmol) | 0.05 ± 0.01 | 0.03 ± 0.01 | <.0001 | 0.07 ± 0.01 | 0.08 ± 0.01 | <.0001 |
Max thickness-HFUS (mm) | 1.79 ± 0.05 | 1.86 ± 0.02 | ||||
Max thickness-Mohs (mm) | 1.76 | 1.87 |
BCC, basal cell carcinoma; HFUS, high frequency ultrasound; SFDI, spatial frequency domain imaging; SCC, squamous cell carcinoma.